Paul Hopper
Founder at IMUGENE LIMITED
Net worth: 31 M $ as of 2024-03-30
Profile
Paul A.
Hopper is the founder of Prescient Therapeutics Ltd.
(founded in 1986) and Imugene Ltd.
(founded in 2012).
He is also the founder of Chimeric Therapeutics Ltd.
(founded in 2020).
Currently, Mr. Hopper holds the position of Chairman at Vaxinia Pty Ltd., Executive Chairman at Radiopharm Theranostics Ltd., Managing Director at Cappello Group, Inc., Director at Biolife Science Ltd., President & Director at Radiopharm Theranostics (USA), Inc., MD, Head-Life Sciences & Biotechnology Group at Cappello Global LLC, and Member at Pacific Council on International Policy.
In his former positions, Mr. Hopper served as Executive Chairman at CAQ Holdings Ltd., Viralytics Pty Ltd., and Botanix Pharmaceuticals Ltd.
He was also the Executive Chairman at Arovella Therapeutics Ltd.
from 2019 to 2022.
Additionally, he held various roles such as Chairman-California Chapter at American Australian Association, Executive Chairman at Bioscience Oncology Pty Ltd., Director at Fibrocell Science, Inc., Director at Advanced Biotherapy, Inc., Independent Non-Executive Director at Somnomed Ltd., Director at Medaire Ltd., Chief Operating Officer & Director at Acuvax Ltd., Independent Director at EyePoint Pharmaceuticals, Inc., Non-Executive Director at Respiri Ltd., Managing Director at Avantogen Ltd., Independent Director at Scopus Biopharma, Inc., and President at Innovate Oncology, Inc. Mr. Hopper's education includes an undergraduate degree from The University of New South Wales.
Mr. Hopper is also the founder of Pathway Oncology Pty Ltd., Glioblast Pty Ltd., Polynoma LLC, and Alpha Healthcare Ltd...
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IMUGENE LTD
5.77% | 2024-01-31 | 422,219,760 ( 5.77% ) | 29 M $ | 2024-03-30 |
2023-09-20 | 94,137,432 ( 11.12% ) | 2 M $ | 2024-03-30 | |
2022-11-24 | 423,521 ( 0.10% ) | 15 471 $ | 2024-03-30 |
Paul Hopper active positions
Companies | Position | Start |
---|---|---|
IMUGENE LIMITED | Founder | 2012-10-30 |
CHIMERIC THERAPEUTICS LIMITED | Founder | 2020-02-01 |
RADIOPHARM THERANOSTICS LIMITED | Chairman | 2021-02-10 |
Vaxinia Pty Ltd.
Vaxinia Pty Ltd. Pharmaceuticals: OtherHealth Technology Vaxinia Pty Ltd. develops oncolytic cancer viruses. The company is headquartered in Australia. | Chairman | - |
Biolife Science Ltd.
Biolife Science Ltd. Pharmaceuticals: OtherHealth Technology Part of Imugene Ltd., Biolife Science Ltd. is an Australian company that manufactures cancer therapeutic vaccines. The private company is based in Brisbane, Australia. The company was founded by Brian Leedman. Biolife Science was acquired by Imugene Ltd. from Acuvax Ltd. on December 20, 2013 for $4.08 million. | Director/Board Member | - |
Pacific Council on International Policy
Pacific Council on International Policy Miscellaneous Commercial ServicesCommercial Services Pacific Council on International Policy operates as a foreign affairs firm. The firm specializes International Affairs, International Relations, Foreign Policy, Foreign Affairs, Public Policy, National Security, International Economics, Government, Professional Networking, Events, Non Profit, International Policy and International Business, Analysis. The company was founded in 1995 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
Cappello Global LLC
Cappello Global LLC Investment Banks/BrokersFinance Part of Cappello Group, Inc., Cappello Global LLC provides advisory services. The private company is based in Santa Monica, CA. The CEO of the company is Richard Revelins. | Corporate Officer/Principal | - |
Cappello Group, Inc.
Cappello Group, Inc. Investment Banks/BrokersFinance Cappello Group, Inc. is an investment banking firm that provides advisory services such as mergers and acquisitions, equity financing, debt financing, specialized and project financing, strategic advisory, and restructuring. The private company is based in Los Angeles, CA and has subsidiaries in the United States. The company has industry expertise in business services, consumer products and services, energy, financial services, healthcare, industrials, real estate, gaming and hospitality, and technology, media & telecom. The company was founded by Alexander L. Cappello, who has been the CEO since incorporation. | Corporate Officer/Principal | 2005-10-31 |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Radiopharm Theranostics (USA), Inc. is an American company founded in 2021 that develops radiopharmaceutical products for diagnostic and therapeutic uses. | President | - |
Former positions of Paul Hopper
Companies | Position | End |
---|---|---|
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Paul Hopper
The University of New South Wales | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 10 |
---|---|
SOMNOMED LIMITED | Health Technology |
CAQ HOLDINGS LIMITED | Finance |
PRESCIENT THERAPEUTICS LIMITED | Health Technology |
IMUGENE LIMITED | Health Technology |
BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
AROVELLA THERAPEUTICS LIMITED | Health Technology |
RESPIRI LIMITED | Health Technology |
SCOPUS BIOPHARMA INC. | Health Technology |
RADIOPHARM THERANOSTICS LIMITED | Health Services |
Private companies | 22 |
---|---|
Fibrocell Science, Inc.
Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA. | Health Technology |
Cappello Group, Inc.
Cappello Group, Inc. Investment Banks/BrokersFinance Cappello Group, Inc. is an investment banking firm that provides advisory services such as mergers and acquisitions, equity financing, debt financing, specialized and project financing, strategic advisory, and restructuring. The private company is based in Los Angeles, CA and has subsidiaries in the United States. The company has industry expertise in business services, consumer products and services, energy, financial services, healthcare, industrials, real estate, gaming and hospitality, and technology, media & telecom. The company was founded by Alexander L. Cappello, who has been the CEO since incorporation. | Finance |
Advanced Biotherapy, Inc.
Advanced Biotherapy, Inc. Financial ConglomeratesFinance Advanced Biotherapy, Inc. operates as a development stage company. It focuses on the acquiring revenue generating companies or development stage companies through an asset acquisition or other financing. The firm is a subsidiary of Lime Financing Co. The company was founded on December 2, 1985 and is headquartered in Chicago, IL. | Finance |
Medaire Ltd.
Medaire Ltd. Specialty StoresRetail Trade Medaire Ltd. provides medical and travel safety products and services to commercial airlines. The company was founded on April 16, 2002 and is headquartered in Farnborough, the United Kingdom. | Retail Trade |
Acuvax Ltd.
Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | Health Technology |
Viralytics Pty Ltd.
Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Cappello Global LLC
Cappello Global LLC Investment Banks/BrokersFinance Part of Cappello Group, Inc., Cappello Global LLC provides advisory services. The private company is based in Santa Monica, CA. The CEO of the company is Richard Revelins. | Finance |
Innovate Oncology, Inc. | Health Technology |
Pacific Council on International Policy
Pacific Council on International Policy Miscellaneous Commercial ServicesCommercial Services Pacific Council on International Policy operates as a foreign affairs firm. The firm specializes International Affairs, International Relations, Foreign Policy, Foreign Affairs, Public Policy, National Security, International Economics, Government, Professional Networking, Events, Non Profit, International Policy and International Business, Analysis. The company was founded in 1995 and is headquartered in Los Angeles, CA. | Commercial Services |
American Australian Association
American Australian Association Miscellaneous Commercial ServicesCommercial Services American Australian Association is a non-profit organization whose purpose is to promote friendship, cooperation and understanding between the peoples of the United States and Australia through a better understanding of their cultures and societies. The company was founded by Keith Murdoch in 1948 and is headquartered in New York, NY. | Commercial Services |
The Merchants Bank of New York | Finance |
Polynoma LLC
Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The private company was founded by Paul A. Hopper. | Health Technology |
Avantogen Ltd. | Commercial Services |
Alpha Healthcare Ltd.
Alpha Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Alpha Healthcare Ltd. is a private company headquartered in Mallow, Ireland, involved in management consulting services. It was founded by Paul A. Hopper. | Commercial Services |
Biolife Science Ltd.
Biolife Science Ltd. Pharmaceuticals: OtherHealth Technology Part of Imugene Ltd., Biolife Science Ltd. is an Australian company that manufactures cancer therapeutic vaccines. The private company is based in Brisbane, Australia. The company was founded by Brian Leedman. Biolife Science was acquired by Imugene Ltd. from Acuvax Ltd. on December 20, 2013 for $4.08 million. | Health Technology |
Pathway Oncology Pty Ltd.
Pathway Oncology Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Prescient Therapeutics Ltd., Pathway Oncology Pty Ltd. holds a license to anti-cancer technology. The Australian company was founded by Paul A. Hopper. Pathway Oncology was acquired by Prescient Therapeutics Ltd. on May 30, 2014 for $1.74 million. | Commercial Services |
Glioblast Pty Ltd.
Glioblast Pty Ltd. Pharmaceuticals: MajorHealth Technology Glioblast Pty Ltd. engages in neuro-oncology business. The company is headquartred in Sydney, Australia. | Health Technology |
Vaxinia Pty Ltd.
Vaxinia Pty Ltd. Pharmaceuticals: OtherHealth Technology Vaxinia Pty Ltd. develops oncolytic cancer viruses. The company is headquartered in Australia. | Health Technology |
Chimeric Therapeutics Ltd. (Australia) | |
C19 Therapeutics Pty Ltd. | |
Bioscience Oncology Pty Ltd. | |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Radiopharm Theranostics (USA), Inc. is an American company founded in 2021 that develops radiopharmaceutical products for diagnostic and therapeutic uses. | Health Technology |
- Stock Market
- Insiders
- Paul Hopper